Advertisement
Review Article| Volume 34, ISSUE 1, P167-185, March 2014

Download started.

Ok

Methodologies for Measurement of Cardiac Markers

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Biomarkers Definitions Working Group
        Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.
        Clin Pharmacol Ther. 2001; 69: 89-95
        • Baker S.G.
        • Kramer B.S.
        Surrogate endpoint analysis: an exercise in extrapolation.
        J Natl Cancer Inst. 2013; 105: 316-320
        • Fleming T.R.
        • Powers J.H.
        Biomarkers and surrogate endpoints in clinical trials.
        Stat Med. 2012; 31: 2973-2984
        • Venge P.
        • Lindahl B.
        Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on outcome prediction.
        Clin Chem. 2013; 59: 976-981
        • Lee W.Y.
        Tris (2,2'-bipyridyl)ruthenium(II) electrogenerated chemiluminescence in analytical science.
        Mikrochim Acta. 1997; 127: 19-39
        • Cho I.H.
        • Paek E.H.
        • Kim Y.K.
        • et al.
        Chemiluminometric enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor based on cross-flow chromatography.
        Anal Chim Acta. 2009; 632: 247-255
        • Mark D.
        • Haeberle S.
        • Roth G.
        • et al.
        Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications.
        Chem Soc Rev. 2010; 39: 1153-1182
        • Theilacker N.
        • Roller E.E.
        • Barbee K.D.
        • et al.
        Multiplexed protein analysis using encoded antibody-conjugated microbeads.
        J R Soc Interface. 2011; 8: 1104-1113
        • Han K.N.
        • Li C.A.
        • Seong G.H.
        Microfluidic chips for immunoassays.
        Annu Rev Anal Chem (Palo Alto Calif). 2013; 6: 119-141
        • Belabani C.
        • Rajasekharan S.
        • Poupon V.
        • et al.
        A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samples.
        J Immunol Methods. 2013; 387: 1-10
        • Rodriguez H.
        • Tezak Z.
        • Mesri M.
        • et al.
        Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA Interagency Oncology Task Force on Molecular Diagnostics.
        Clin Chem. 2010; 56: 237-243
        • Ekins R.P.
        • Chu F.W.
        Multianalyte microspot immunoassay - microanalytical “compact disk” of the future.
        Clin Chem. 1991; 37: 1955-1967
        • Meikle P.J.
        • Grasby D.J.
        • Dean C.J.
        • et al.
        Newborn screening for lysosomal storage disorders.
        Mol Genet Metab. 2006; 88: 307-314
        • Apple F.S.
        • Ler R.
        • Murakami M.M.
        Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population.
        Clin Chem. 2012; 58: 1574-1581
        • Wu A.H.
        • Agee S.J.
        • Lu Q.A.
        • et al.
        Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology.
        Clin Chem. 2009; 55: 196-198
        • Apple F.S.
        • Collinson P.O.
        Analytical characteristics of high-sensitivity cardiac troponin assays.
        Clin Chem. 2012; 58: 54-61
        • Parsonage W.A.
        • Tate J.R.
        • Greenslade J.H.
        • et al.
        Effect of recalibration of the hs-TnT assay on diagnostic performance.
        Clin Chem Lab Med. 2013; : 1-3
        • Wu A.H.
        • Christenson R.H.
        Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care.
        Clin Biochem. 2013; 46: 969-978
        • Ungerer J.P.
        • Marquart L.
        • O'Rourke P.K.
        • et al.
        Concordance, variance, and outliers in 4 contemporary cardiac troponin assays: implications for harmonization.
        Clin Chem. 2012; 58: 274-283
        • Savukoski T.
        • Twarda A.
        • Hellberg S.
        • et al.
        Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin.
        Clin Chem. 2013; 59: 512-518
        • Lippi G.
        • Cervellin G.
        Degradation of troponin I in serum or plasma: mechanisms, and analytical and clinical implications.
        Semin Thromb Hemost. 2012; 38: 222-229
        • Biener M.
        • Katus H.A.
        • Giannitsis E.
        Challenges of serial troponin testing: a symphony in need for harmony.
        Int J Cardiol. 2013; 168: 4542
        • Tamm N.N.
        • Semenov A.G.
        • Seferian K.R.
        • et al.
        Measurement of B-type natriuretic peptide by two assays utilizing antibodies with different epitope specificity.
        Clin Biochem. 2011; 44: 257-259
        • Liang F.
        • O'Rear J.
        • Schellenberger U.
        • et al.
        Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
        J Am Coll Cardiol. 2007; 49: 1071-1078
        • Koerbin G.
        • Abhayaratna W.P.
        • Potter J.M.
        • et al.
        Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays.
        Clin Biochem. 2013; 46: 1636-1643
        • Zaninotto M.
        • Vernocchi A.
        • Di S.F.
        • et al.
        Assay performance improved, but which “scorecard” designation for Vitros Troponin I?.
        Clin Chim Acta. 2012; 413: 826-828
        • de Lemos J.A.
        Increasingly sensitive assays for cardiac troponins: a review.
        JAMA. 2013; 309: 2262-2269
      1. In vitro diagnostic medical devices - measurement of quantities in biological samples - metrological traceability of values assigned to calibrators and control materials. ISO 17511. International Organization for Standardization, Geneva (Switzerland)2003